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An injectable non-cross-linked 
hyaluronic-acid gel containing 
therapeutic spheroids of human 
adipose-derived stem cells
Jingwei Feng1,2, Kazuhide Mineda1,3, Szu-Hsien Wu1, Takanobu Mashiko1, Kentaro Doi1, 
Shinichiro Kuno1, Kahori Kinoshita1, Koji Kanayama1, Rintaro Asahi4, Ataru Sunaga4 &  
Kotaro Yoshimura  1,4
For chronic wounds, the delivery of stem cells in spheroidal structures can enhance graft survival and 
stem cell potency. We describe an easy method for the 3D culture of adipose-derived stem/stromal cells 
(ASCs) to prepare a ready-to-use injectable. We transferred suspensions of monolayer-cultured ASCs 
to a syringe containing hyaluronic acid (HA) gel, and then incubated the syringe as a 3D culture vessel. 
Spheroids of cells formed after 12 h. We found that 6 × 106 ASCs/ml in 3% HA gel achieved the highest 
spheroid density with appropriate spheroid sizes (20–100 µm). Immunocytology revealed that the stem 
cell markers, NANOG, OCT3/4, SOX-2, and SSEA-3 were up-regulated in the ASC spheroids compared 
with those in nonadherent-dish spheroids or in monolayer cultured ASCs. In delayed wound healing 
mice models, diabetic ulcers treated with ASC spheroids demonstrated faster wound epithelialization 
with thicker dermis than those treated with vehicle alone or monolayer cultured ASCs. In irradiated skin 
ulcers in immunodeficient mice, ASC spheroids exhibited faster healing and outstanding angiogenic 
potential partly by direct differentiation into α-SMA+ pericytes. Our method of 3D in-syringe HA 
gel culture produced clinically relevant amounts of ready-to-inject human ASC microspheroids that 
exhibited superior stemness in vitro and therapeutic efficacy in pathological wound repair in vivo.
About 1% of the population suffers from some form of chronic wound at any given time1. Chronic wounds require 
repeated interventions and are often refractory to traditional therapies, causing tremendous suffering for patients 
and presenting a challenge for clinicians. Delayed wound healing essentially results from incompetent “seed” 
(stem/progenitor cells) and/or unhealthy “soil” (bioactive factors and matrix components)2. Adipose-derived 
stem/stromal cells (ASCs) are recognized for their capability to differentiate into fat, bone, and cartilage3. There 
has been an exponential increase in the number of clinical trials utilizing human ASCs (hASCs) because of the 
immunomodulatory function, trophic function, multipotency, and simple acquisition of ASCs4, 5. ASCs displayed 
reparative and regenerating effects in preclinical and clinical studies, strongly suggesting that they play a critical 
role in healing/remodeling after soft-tissue injury4–6.
In model systems and regenerative therapy, the ASC culture evolves from a monolayer culture to sheet, sphe-
roid, organoid, and, ultimately, large multiplexed systems, mimicking the body’s organization from cells to layered 
tissues or simple organs7. Monolayer-cultured cells are poorly retained in local transplantations, nullifying the 
therapeutic intent or resulting in unexpected stem cell behaviors8–10. On the other hand, evolved three dimen-
sional (3D) culture systems help to build sophisticated multicellular constructs with extracellular matrix (ECM) 
and demonstrate better therapeutic efficacy9, 10, leading to a new trend in stem cell therapy11–13. Among the 3D 
culture systems, the spheroid is comparatively simple to prepare and well-studied. Although there are many 
methods for 3D culture and spheroid formation, only the methods with simple equipment, high output, and 
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low cost can be clinically relevant. Force floating on non-adherent dishes (NAD) is the most frequently adopted 
method, but the products often include many large aggregations with severe central necrosis10, 14. Matrices of bio-
material help to form spheroids of relatively uniform size and can efficiently produce therapeutic spheroids15, 16. 
Hyaluronic acid (HA) is a naturally derived ECM component that is widely used as an injectable material by oph-
thalmologists, arthrologists, and cosmetic surgeons. Previously, we found that HA served as a fine matrix for ASC 
spheroid formation. Spheroids prepared using HA gel have superior plasticity, trophic effects, and therapeutic 
potential for promoting tissue regeneration15.
Using a syringe as a 3D culture vessel, we developed a new method to make ASC spheroids in a syringe filled 
with HA gel (HA ASC spheroids). The method is very simple and productive and requires no special effort to 
extract the spheroids from the HA gel for therapies. We performed in vitro analyses to assess the viability, size, and 
stemness of the ASCs produced. In addition, we performed in vivo experiments using chronic-wound models to 
test the therapeutic efficacy and elucidate how the ASC spheroids facilitate wound healing.
Results
Optimization of HA ASC spheroid formation via 3D culture in syringe. Cell viability. After seed-
ing the ASCs in HA gel for 3D culture, we observed cellular aggregation as early as 6 h (Fig. 1A). The morphology 
of the spheroids (HA ASC spheroids) remained similar between 24 h and 48 h of culture, suggesting maturation 
of the spheroid formation (Fig. 1A). The cells were initially aggregated loosely, but spheroids with collagen type I 
expression became clearly margined at 12 h (Fig. 1A,B). We occasionally detected PI+ dead cells in the center of 
spheroids in the 12 h sample (Fig. 1B). Starting as early as about 24 h, the cell death rate increased logarithmically 
as the culture time progressed and the dead cells were seen not only in the center but also in the outboard of the 
spheroid (Fig. 1C). Severe cell death (>80%) occurred in the groups with higher ASC seeding densities (4 × 106/
ml, 6 × 106/ml, and 8 × 106/ml); however, in the 12 h sample, the death rate had not yet entered the logarith-
mic stage, and there was only 8.4% difference between the groups seeded with 2 × 106/ml and 6 × 106/ml ASCs 
(p < 0.01; M2e6 vs. M6e6, p < 0.05), respectively. The death rates in those groups ranged from 11.7% (±0.019) to 
20.1% (±0.010). The group seeded with 8 × 106/ml ASCs suffered from the most cell death (37.6% ± 0.029) at 12 h 
(M2e6,4e6,6e6 vs. M8e6, p < 0.01).
Figure 1. Optimization of spheroid formation and cell viability. (A) Temporal change of human ASC spheroid 
formation during in-syringe culture. Scale bars = 200 µm. (B) Light-microscopic images of spheroids after 
12 h culture (left). All nucleate cells were labeled with Hoechst (blue), while dead cells were labeled with PI 
(red; middle). Spheroids expressed Collagen type 1 (green) in their center (right). Scale bars = 50 µm. (C) 
Quantification of dead cells produced by different seeding densities at different time points during in-syringe 
culture (n = 3 random fields of 500 × 700 µm; 500–1000 cells/field; *F = 49.48; p < 0.0001).
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Spheroidal formative efficiency. ASCs migrate less in thicker gels than in thinner gels. In our previous study15, 
HA gels thinner than 3% did not provide enough floatation, usually resulting in very large cellular aggregates at 
the gel bottom. At the other extreme, very thick HA gels prevented the gathering of cells. We found that 5% HA 
was the most concentrated gel that showed decent spheroid formation and was still able to be injected through a 
small (30 gauge) needle. Therefore, we chose 3%, 4%, and 5% HA as the concentrations for further testing. Based 
on the viability assays, we selected ASC concentrations of 2 × 106/ml, 4 × 106/ml, and 6 × 106/ml. The higher 
seeding densities tended to produce higher numbers of spheroids, whereas the higher HA concentrations tended 
to produce smaller spheroids (Fig. 2A). Small particles (<20 µm) formed in every group, but the number of them 
should be minimized to improve the spheroidal formative efficiency. We found that the number of spheroids 
with size > 20 µm did not always increase as we put in more cells. In the group seeded with 6 × 106/ml ASCs, the 
number of spheroids >20 µm decreased with the hardening of the HA gel with the presence of a large amount of 
undersized particles in the thick gel. In 3% HA, 6 × 106/ml ASCs yielded 13.3 ± 1.21 × 104 spheroids and seemed 
an optimal concentration for that density (p = 0.008) (Fig. 2B). In 4% HA, 4 × 106/ml ASCs yielded the highest 
number of spheroids (11.3 ± 0.21 × 104, p = 0.009). The total spheroid count did not, however, provide enough 
information to identify a single distinguished group.
Morphological analysis of HA ASC spheroids. Significant cell death appeared when the spheroid diameter 
reached approximately 100 µm (Fig. 2C). Assuming that the favorable size is 20–100 µm17, we calculated the 
Figure 2. Optimization of spheroid preparation. (A) Representative microscopic images of spheroids after 
12 h culture with different HA concentrations and seeding densities. Scale bars = 50 µm. (B) Total numbers of 
spheroids (>20 µm) yielded after 12 h culture. (C) Fluorescent microscopic images of spheroids of different 
sizes. Dead cells were labeled by PI (red) while nuclei were labeled with Hoechst (blue). Scale bars = 100 µm. 
(D) Size-distribution histogram of the products; n = 3 independent experiments; 50–200 particles of product 
analyzed in each sample; *p = 0.008, **p = 0.009, ***p = 0.034.
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numbers of spheroids that were undersized, oversized, and of favorable size to find the best combination of HA 
concentration and seeding density (Fig. 2D). There was a sophisticated relationship among gel concentration, 
cell number, and spheroid size. Although the higher seeding density might result in more spheroids, it could also 
promote the formation of larger spheroids and lead to a decreased number of spheroids. Likewise, the higher HA 
concentration could prevent the formation of large spheroids, thus increasing the number of microspheroids. The 
group with 3% HA and 6 × 106/ml ASCs, produced the largest number of spheroids 20–100 µm (around 8.5 × 104/
ml). The peak of the size distribution lay in an even better range (40–60 µm). We therefore decided to prepare 
spheroids by seeding 6 × 106/ml ASCs in 3% HA gel and to culture the cells for 12 h for further studies.
Stem cell marker expression in HA ASC spheroids, NAD ASC spheroids and 2D cultured 
ASCs. The immunohistocytology results indicated that spheroids prepared by 3D culture in HA gel (HA ASC 
spheroids) showed higher expression levels of NANOG, Oct-4, and SOX2 than 2D cultured ASCs or spheroids 
prepared with non-adherent dishes (NAD ASC spheroids) (Fig. 3A). NAD ASC spheroids expressed NANOG 
weakly only in the center part of the spheroid, leaving the outer layer of cells NANOG-negative. There was much 
stronger NANOG staining throughout the HA ASC spheroids. HA ASC spheroids showed significantly higher 
levels of SSEA-3, which is a marker for muse cells18, than NAD ASC spheroids (p = 0.043) and 2D cultured ASCs 
(p = 0.040) (Fig. 3B).
Therapeutic effects of HA ASC spheroids in diabetic-mouse wound healing. The mice injected 
with HA ASC spheroids healed more rapidly than those injected with 2D cultured ASCs or with vehicle (HA) 
alone (day 10: 31% smaller vs. 2D cultured ASC group; day 14: 17% smaller vs. 2D cultured ASC group; Fig. 4A). 
At week 3, wound closure was mostly completed in the HA ASC spheroid-treated mice, whereas the wound beds 
of mice treated with vehicle alone remained hyperemic.
We histologically evaluated the wound center and wound margin separately and found that scar tissue had 
formed in the central area (Fig. 4B). Mallory-azan staining suggested that the subcutaneous adipose layer in the 
marginal area was thicker in the HA ASC spheroid-treated mice, while damaged adipocytes, forming large round 
oil droplets, were frequently seen in the adipose layer of vehicle-treated mice. In the HA ASC spheroid-treated 
mice, the normal dermis structure with abundant collagen fiber were seen. In the other mice (2D cultured 
ASC-treated or vehicle-treated), the scar tissue was seen as inflammatory collagen-deficient areas (dashed lines 
in Fig. 4B). The thickness of the collagen layer in the ulcer center indicated that the HA ASC spheroids promoted 
collagen deposition into the wound (p = 0.026).
Immunohistology indicated healthier subcutaneous tissue in the HA ASC spheroid-treated wounds (Fig. 4C). 
The HA ASC spheroid-treated wounds contained more viable adipocytes (perilipin+) than those treated with 
2D cultured ASCs or with vehicle alone. The matured adipocytes were arranged in an orderly fashion in HA 
ASC spheroid-treated wounds, while there were also areas with some small (regenerating) adipocytes squashed 
together. In the dermis layer (marked by dashed lines in upper images of Fig. 4C), the HA ASC spheroid-treated 
wounds displayed well-developed microvasculature (vWF+) in the adipose inflammatory area, whereas the 
vehicle-treated wounds displayed less capillarization. The HA ASC spheroid-treated wounds contained fewer oil 
drops surrounded by Mac-2-positive macrophages forming “crown-like structures” (marked by*), indicating less 
inflammation and adipocyte necrosis (lower images of Fig. 4C).
Therapeutic effects of HA ASC spheroids on wound healing in irradiated tissue. The ulcers cre-
ated in the irradiated tissue showed retarded healing compared with those in the normal tissue. By day 10, the 
vehicle-treated ulcers in normal tissue were essentially closed, while the vehicle-treated ulcers in irradiated tissue 
were left unhealed until day 18 (Fig. 5).
The HA ASC spheroid-treated irradiated ulcers, similarly to the vehicle-treated non-irradiated ulcers, showed 
better epithelialization and wound healing (wound area: 31.45%) than the 2D cultured ASC-treated irradi-
ated ulcers (48.95%) by day 4, although the 2D cultured ASC-treated irradiated ulcers healed faster than the 
vehicle-treated irradiated ulcers (76.16%) (Hday4 = 9.36, pday4 = 0.0249). The HA ASC spheroid-treated irradiated 
ulcers almost healed by day 10 (2.15%) or 13 (1.69%) (p < 0.05 for each pairwise comparison on days 10 and 13), 
whereas the other groups did not achieve full wound closure even on day 18.
Immunohistology revealed the fate of administered 2D cultured ASCs or HA ASC spheroids which were labe-
led with DiI (Fig. 6A). On day 13, many perilipin(+)/DiI(+) cells (yellow cells) were detected in both HA ASC 
spheroid-treated and 2D cultured ASC-treated groups, which suggested that some administered ASCs started to 
differentiate into adipogenic lineages. Mac-2 immunostaining revealed that Mac-2(+) macrophages are located 
closely with DiI(+) ASCs, though the ASCs did not look expressing Mac-2. DiI(+) ASCs were frequently detected 
around vessels, though their exact localization and function remain unclear. DiI(+) ASCs, which differentiated 
into vascular mural cells and expressed αSMA, were occasionally seen in HA ASC spheroid-treated ulcers, but 
not in 2D cultured ASC-treated samples.
The whole-mount image of HA ASC spheroid-treated specimens revealed that DiI(+) ASCs arranged in a 
tubular structure along the isolectin(+) linear structure of endothelial cells in the dermis on day 7 (Fig. 6B). On 
day 13, DiI(+) tubular structures wrapping an isolectin(+) capillary were seen. Most of the DiI(+) cells laid 
around the capillaries, whereas DiI/isolectin double-positive cells were also detected occasionally.
Discussion
Researchers have made many attempts to find ways to enhance mesenchymal stem cell (MSC) therapy for tis-
sue repair. Delivery in spheroids was reported to enhance the cell stemness, differentiation/engraftment, and 
local retention9, 10, 16, 17, 19. Those beneficial effects were attributed to the cell-matrix microenvironment within 
the spheroids, which provides physiological/functional condition, mechanical support, and migration control20. 
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Compared with other spheroid-preparation methods, our method does not involve any complicated tools or bio-
mimetic materials and requires no spheroid-retrieving procedure for therapeutic use. Our method also increases 
the ASC loading number by more than one order of magnitude, from 3–7.5 × 104/cm2 9, 10 or 2.5 × 105/ml15 to 106/
ml. That increase could allow physicians to process large quantities of cells using a less demanding procedure. 
Furthermore, the spheroids and matrix HA can be easily injected to a target organ/tissue through needles as fine 
as 27–30 gauge.
Because of a limit to the diffusion, cells in the center of large-sized spheroids suffer from hypoxia and malnu-
trition, leading to central necrosis10, 21, 22. Central necrosis was reported when spheroids of mesenchymal stem 
cells reached a diameter of 200 µm in a suspension rocking-culture system23. In this study, HA ASC spheroids 
produced central cell death at sizes exceeding 100 µm. Therefore, we set the size upper bound to 100 µm.
One of the advantages of spheroids is that they unlikely migrate too much because of their large size. Low 
retention of locally administrated cells has been reported as a crucial obstacle to accomplishing functional 
Figure 3. Stem cell marker expression of spheroids. (A) Immunohistology for nuclear stem cell markers, 
NANOG, OCT4 and SOX2, in ASCs after 12 h culture on 2D petri dish, non-adhesive dish, and HA gel. Nuclei 
were labeled with Hoechst (blue). Scale bars = 50 µm. (B) SSEA-3 expression in ASCs 12 h after seeding on 2D 
petri dish (2D), non-adhesive dish (NAD), and in HA gel (HA). Bar graph showed the relative quantification of 
the SSEA-3 fluorescence. p = 0.019, *,**p < 0.05; n = 3 independent experiments. Scale bars = 100 µm.
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Figure 4. Wound healing of skin defects in diabetic mice. (A) Representative photos of wound healing in full-
thickness cutaneous ulcers (left) and quantification of wound-opening sizes at different time points (right) in 
db/db mice. The inner diameter of the splints was 14 mm; n = 4 ulcers; *pday10 = 0.0245; *pday14 = 0.021. (B) 
Mallory-Azan trichrome stain of wound-tissue samples harvested 24 days post surgery (upper). Collagen was 
stained blue. Wound pathohistology was evaluated via quantification of dermal collagen deposition (lower). 
The dashed line indicates the collagen-poor area in the dermis; n = 4 ulcers; five points were photographically 
measured in each sample; *p = 0.040, **p = 0.043. Scale bars = 200 µm. (C) Immunofluorescence of the adipose 
layer of the wound: viable adipocytes (perilipin, white), macrophages (mac-2, green), vasculature (vWF, red), 
and nuclei (blue). *Represents crown-like structures which are perilipin-negative round area (oil drops) 
surrounded by Mac-2-positive infiltrated macrophages. Scale bars = 100 µm.
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benefits14, 16, 24. Free cells injected into subcutaneous tissue could enter the lymph capillaries and travel through 
the lymph system. Clinical evidence of stem cell migration, such as ectopic lymphadenopathy, was found in 
patients that received local injections of cell suspensions8. The smallest lymphatic vessels (not capillaries) reside in 
the subcutaneous tissue, with typical diameters around 20 µm25, 26. We chose 20 µm as the lower bound that could 
theoretically prevent substantial migration.
It has been postulated that ASCs initiate or enhance skin wound repair by differentiating into skin cells; how-
ever, only a very small amount of ASCs can be integrated into the regenerated tissue9, 18, 27. In our experiments, the 
expression of pluripotency markers (NANOG, OCT-4, SOX2, and SSEA-3) was enhanced after 3D culture in HA 
gel. Previously, many stem cell markers were found to be elevated at the RNA level as well as the protein level15. 
The physiological microenvironment of stem cells is considered to regulate the stemness by enhancing NANOG 
and OCT-426. The spheroidal structure mimics the physiological niche environment and may help to maintain the 
cells in an undifferentiated stage9, 16, 28, 29. The HA substrate was also reported to help embryonic stem cells (ESCs) 
remain undifferentiated in vitro and in vivo30, 31. In some cancer cell lines, HA activates the major receptor CD44 
and promote the expression of NANOG32, OCT-4, and SOX233. Evidence has shown that by binding CD44, HA 
promotes Rho/ROCK signaling and enhances the stemness of MSCs16.
Figure 5. Macroscopic evaluation of wound healing in irradiated tissue of nude mice. (A) Sequential views of 
cutaneous ulcers (8 mm in diameter) treated with different cellular products or vehicle in irradiated or normal 
skin. The inner diameter of the splint was 14 mm. (B) Quantification of wound healing at different time points. 
n = 3 mice; pday4 = 0.0249, pday7 = 0.0249, pday13 = 0.0330, pday16 = 0.0364. ▲Represent p < 0.05.
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Another possible cause of the elevated ESC markers is hypoxia. It could be induced by spheroidal structure 
and high-density culture gel environment. We have learned that the spheroid center has a lower oxygen tension 
than the outer layers10, 14, and hypoxia can mediate or regulate the expression of NANOG and OCT-434–36. In HA 
ASC spheroids, we found a NANOG-negative surface zone and a NANOG-positive core zone of spheroids (Fig. 3 
A-middle), suggesting NANOG expression may correlate with oxygen level created by innate structure of sphe-
roid. The high-density culture may further deteriorate the hypoxia, leading to ESC marker upregulation or cell 
death37. Further studies will be necessary, however, to explore the mechanisms by which the ASC-HA interaction 
and microenviromental cues enhance the ASC potency. Although HA ASC spheroids have elevated ESC markers, 
their mesenchymal markers such as CD90 persist indiscriminately15, which suggests that HA ASC spheroids do 
not raise ESC-like safety concern.
Multilinage differentiating stress enduring (MUSE) cells, marked by SSEA-3, show superior multi-/pluri-potency 
compared with regular MSCs38. MUSE cells made up only about 1% of 2D cultured ASCs and were expanded only 
in 3D culture38, 39, including spheroidal culture in HA gel15. Our HA ASC spheroids contained more SSEA-3+ cells 
than the NAD ASC spheroids and 2D cultured ASCs, which may help to show better therapeutic capacities.
We tested to explore the therapeutic potential in chronic wounds in ischemic conditions using two distinct 
animal models. In our diabetic-ulcer mice model, human HA ASC spheroids helped the wounds heal faster 
in the proliferative/regenerative stage of healing, although long-term retention of cells was not expected. In 
the wound periphery, the dermis showed signs of injury including severe inflammatory-cell infiltration and 
macrophage-surrounded dead adipocytes (crown-like structure). The HA ASC spheroids promoted successful 
repair of adipose tissue and abundant angiogenesis in the regenerating zone. In the wound center, which was 
already epithelialized, there was a neat and ordered collagen layer in the wounds treated with HA ASC spheroids. 
Figure 6. Immunohistological tracing of administered ASCs in irradiated skin ulcers of nude mice. (A) 
Immunohistological views of irradiated ulcer specimens 13 days after surgery and transplantation for tracing of 
administered ASCs (DiI-labeled cells). Cell fates were visualized by immunostaining for perilipin, Mac-2, and 
αSMA. Scale bars = 50 µm. (B) Whole mount staining of the irradiated wound tissue at days 7 and 13. Vascular 
endothelial cells were labeled by isolectin. Scale bars = 50 µm.
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The other two treatments (2D cultured ASC-treated and vehicle-treated) resulted in delayed healing as well as 
inflamed and collagen-poor dermis. We reported previously that HA ASC spheroids secrete more growth factors 
in hypoxic conditions than monolayer-cultured cells15. Furthermore, SSEA-3(+) MUSE cells showed greater par-
acrine function and benefit to diabetic wound healing40. That might explain why the HA ASC spheroids acceler-
ated and improved the healing of the diabetic ulcers in our db/db mouse model.
Another animal model is a nude mice with radiation-induced tissue damage. The cells, which are selectively 
killed by ionizing radiation, are dividing cells such as cancer cells and activated stem cells. The depletion of stem 
cells, stromal elements, and microvasculature thrombosis induced by hypoxia and ischemia caused late radiation 
damage and impaired healing competency41. The differentiation capacity and paracrine effects of ASCs can facil-
itate adipogenesis and angiogenesis, ameliorating the infertile condition of the irradiated tissue and improving 
wound healing. ASCs do not, however, usually incorporate into the vasculature if they are grafted as single cells9, 
10. In contrast, in the HA ASC spheroid-treated radiated ulcers, we found that some of the transplanted ASCs 
became α-SMA+ in the dermis. Furthermore, those cells aligned in a tubular fashion before the end of the first 
week after transplantation and later appeared to become functional blood vessels. We believe that DiI-labeled 
ASCs from the HA ASC spheroids dissociated, migrated, and partly differentiated into pericytes and contributed 
to the restoration of vascular structures. The enriched SSEA-3+ MUSE cells in HA ASC spheroids might help for 
the superior differentiation and contribution to vascular formation.
Conclusion
We investigated the therapeutic potential and limitations of ASCs delivered in suspension and developed a new, 
simple, 3D culture method using HA as a culture matrix. In only 12 h, in-syringe cultures of human ASCs can 
yield ready-to-inject cellular spheroids. The spheroids are relatively homogenous in size (20–120 μm) and express 
higher levels of stem cell markers than spheroids from non-adherent dish cultures. In-syringe culture allows 
clinicians to work with millions of cells using only a few simple procedures, which avoids loss of cellular viability 
and recovery. ASC spheroids prepared from culture in HA gels demonstrated superior efficacy in both refractory 
wounds created in diabetic mice and irradiated tissue in immunodeficient mice, which suggested both paracrine 
effects and functional differentiation.
Materials and Methods
All experimental protocols involving human subjects in this study were performed in accordance with relevant gov-
ernment guidelines and approved by the institutional review board (IRB) of the University of Tokyo Hospital. were 
performed in accordance with the relevant guidelines and regulations. Prior to the procedure, each patient provided 
her informed consent using an IRB approved protocol. The protocols of animal experiments followed the relevant 
guidelines and were approved by the animal experimental committee of University of Tokyo School of Medicine.
Cell isolation and culture. Liposuction aspirates were obtained from 6 healthy non-obese female donors 
aged 25–57 undergoing liposuction of the abdomen or thighs. Human ASCs were isolated from the aspirated fat 
as described previously3. Briefly, the aspirated fat was washed with phosphate-buffered saline (PBS) and digested 
on a shaker at 37 °C in PBS containing 0.075% collagenase for 30 min followed by centrifugation (700 g, 5 min). 
The pellets were rinsed, filtered and resuspended. The suspension was disseminated and cultured at 37 °C in a 
Figure 7. ASC spheroid formation in HA gel. Schematic diagram of the preparation of ready-to-inject HA 
spheroids. HA powder was weighed and transferred to a syringe. Monolayer-cultured ASCs were trypsinized, 
counted, suspended in growth medium, aspirated into the syringe, and mixed with the powder, which was then 
allowed to dissolve for 10 min. The plunger was drawn back to assure air exchange through the needle. The 
needle cap then closed, and the syringe was incubated at 5% CO2 and 37 °C. The gel slowly sank to the lower half 
of the syringe.
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humid 5% CO2 atmosphere. The culture medium was Dulbecco’s Modified Eagle Medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS). Primary cells were cultured for 7 days and were defined as passage 0.
3D culture of hASC spheroids with HA gel. We weighed non-cross-linked sodium hyaluronate powder 
(average molecular weight of 1,000 kDa, Kikkoman Biochemifa Company, Tokyo, Japan, http://biochemifa.kik-
koman.co.jp) inside a tissue-culture hood using a 2.5 ml luer-lock syringe as a weighing tube. As the HA powder 
was a sterilized (pharmaceutical grade) product, no special sterilization was needed for preparation of the HA gel. 
After transferring the desired amount of HA powder to the syringe [e.g., 30 mg HA for preparing 3% (w/v) HA 
gel of 1 ml in volume], we trypsinized and counted monolayer-cultured, first-passage or second-passage hASCs, 
resuspended the desired amount of cells in 1 ml DMEM supplemented with 10% FBS, aspirated the cell suspen-
sion into the syringe containing the HA powder, and inverted the syringe several times to mix the contents. The 
mixture became sticky gel over time depending on the concentration of HA powder. The cell-containing HA gel 
became homogenous without any additional culture medium. Later, we created some air space within the syringe 
by drawing the plunger back and replaced the original needle with an 18-gauge needle. Partial tension of oxy-
gen (pO2) tension of the fluid in the syringe was measured with an oxygen monitor using a wire electrode (Eiko 
Kagaku, Tokyo, Japan). After confirming normoxia in the syringe, we laid the syringe flat in a 37 °C and 5% CO2 
incubator (Fig. 7). We harvested the culture products at several different time points for further analysis.
Dead cell quantification in hASC spheroids. We conducted a viability assay in order to optimize the 
in-syringe culture time and seeding density. We used DMEM with 1% Hoechst (v/v) and 0.5% propidium iodide 
(v/v) (PI) to label the cell nuclei and dead cells, respectively. We sampled and stained the cellular products at 
37 °C for 10 min and took photographs with a fluorescence microscope (Keyence, Osaka, Japan). We performed 
“Z-stack” scans of 200 µm thickness and quantified using the BZ-II analyzer software (Keyence). n = 3 independ-
ent experiments, each includes random fields of 500 × 700 µm; 500–1000 cells/field.
Spheroid count and morphological analysis of hASC spheroids. After a series of preliminary tests, 
we chose 3%, 4%, and 5% HA gel to prepare hASC spheroids. For each concentration, we seeded 2 × 106, 4 × 106, 
and 6 × 106 cells and cultured the cells for 12 h. For spheroid number count, we extracted spheroids from HA by 
saline washing to include more particles and took phase-contrast photographs. Each sample of the same volume 
included 50–200 particles over 20 μm. For spheroid size measurement, we took phase-contrast photos of the 
original products to achieve best measurement accuracy by a software. Each sample of the same volume included 
50–200 particles. We used the two different BZ-II analyzer softwares to measure the particle number and size, 
respectively. We performed PI staining to visualize the dead cells in spheroids of different sizes. Size distribution 
analysis included 3 independent experiments; 50–200 particles of product analyzed in each sample.
Immunocytology of hASC spheroids. We harvested the hASC spheroids prepared in HA gels (HA ASC 
spheroids) and compared them with spheroids made using a non-adherent dish (NAD ASC spheroids). We used 
3D microtissue petri dishes (non-adherent) to make comparable spheroids of similar size to the spheroids in HA 
gel. We added 20,000 hASCs in 190 µl DMEM (10% FBS) to a single agarose 256-well microdish and harvested 
the cells after 12 h of floating culture. In addition, we prepared another group of monolayer-cultured ASCs (2D 
cultured ASCs) on culture slides. We used the harvested spheroid pellets to make frozen blocks. We cut and fixed 
sections 7 µm thick and then blocked the sections. We used the following primary antibodies: NANOG antibody 
[N3C3] (GeneTex, Irvine, CA), OCT4 antibody (GeneTex), SOX2 antibody (GeneTex), anti-SSEA-3 antibody 
(EMD Millipore, Darmstadt, Germany), and anti-collagen I antibody (Abcam, Cambridge, U.K.). We diluted 
the antibodies 1:200 (collagen type I antibody 1:500) and incubated them for 16 h at 4 °C. We then incubated the 
samples with secondary antibody of goat anti-rabbit IgG Alexa Fluor 594, goat anti-rabbit IgG Alexa Fluor 488, or 












































Table 1. Materials used for immunofluorescence.
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Mallory-Azan trichrome stain and evaluation of collagen deposition. We fixed the wound samples, 
embedded them in paraffin, and cut 5 µm sections. We then stained the specimen with Mallory-Azan solution 
following manufacturer’s instruction. We then inspected the slides by microscopy (Keyence) and took images 
of the healed dermis. We identified the ulcer center as an adipose-free, muscle-free, and collagen-rich area. We 
measured the dermal thickness by dividing the blue (collagen) dermal area by the width of wound center zone 
using a BZ-II analyzer. We compared the dermal thickness between treatment groups.
Four-color immunofluorescence. We cut the zinc-fixed paraffin blocks into 5 µm sections and deparaffin-
ized, rehydrated, and incubated them in a container with target-retrieval solution (pH = 9) by boiling the con-
tainer in water for 20 min. We then permeabilized the sections in 0.1% triton-X TBS and blocked them with 1% 
BSA in buffer for 1 h. We prepared primary and secondary antibody solutions in TBST (0.1% Tween 20, 1% BSA) 
with the antibodies listed in Table 1. We incubated the samples in the primary antibody solution for 16 h at 4 °C 
and then washed them with three changes of TBS. We diluted the secondary antibodies and Hoechst 200× in 
TBST and incubated them with the sections for 1 h, followed by another three changes of TBS, and mounting. We 
used a fluorescent microscope with the listed filters (Table 1) to view the slides and take photographs.
DiI labeling of the hASC spheroids. We cultured first-passage hASCs on a petri dish with DMEM sup-
plemented with 10% FBS, stained the cell suspension with 2 μM CM-DiI (Thermo Fisher Scientific) in Hank’s 
balanced salt solution (HBSS) at 37 °C for 5 min and then at 4 °C for 15 min, and plated them back onto the dishes. 
For the next 2 days, we repeated the staining procedure daily to obtain the optimal cellular fluorescence.
Whole-mount staining and imaging. We euthanized the mice and harvested and embedded fresh 
wound-skin samples to make frozen blocks. We stained sections 20 µm thick with the following dye buffer: 200× 
Hoechst, isolectin GS-IB4, and Alexa Fluor 488 conjugate in HBSS buffer. We stained the sections for 30 min at 
37 °C in the dark, washed them, and sent them directly for confocal microscopy (Leica, Wetzlar, Germany). We 
examined the subcutaneous layer, scanning a total of 15 µm tissue depth.
Mouse diabetic-ulcer model. The care of B6-db/db mice (BKS.Cg/Leprdb/m/JCL, 8-week-old male) was 
conducted in accordance with institutional guidelines using a protocol approved by the Animal Experimental 
Committee of the University of Tokyo. We anesthetized the mice by isoflurane inhalation, depilated them, and 
created two full-thickness cutaneous wounds (8 mm diameteron both sides dorsally using a sterile circular biopsy 
punch. We then placed a donut-shaped silicone splint to prevent wound contraction. We directly injected 100 μl 
human ASC spheroids (prepared from 0.6 × 106 ASCs, cultured in 3% HA gel for 12 hours; HA ASC spheroids) by 
27-gauge needle into four different points of subcutis at each wound periphery (n = 4 ulcers). We injected the same 
number of monolayer cultured human ASCs grown on a normal petri dish (2D cultured ASCs) and mixed with 
3% w/v HA gel in DMEM supplemented with 10% FBS into another group of mice. We used injections of 3% w/v 
HA gel in DMEM supplemented with 10% FBS as a vehicle (control). We covered the treated wounds with sterile 
silicone gauze and transparent sterile dressings. We photographed the wounds on days 0, 3, 6, 10, 14, 18, and 21. We 
identified the edges of the wound openings as the border of the whitish, dry, membrane-like structure and deter-
mined the areas using Photoshop CS5. After each photograph, we cleaned the wounds and changed the dressings.
Mouse radiation-ulcer model. We purchased 12-week-old male nude mice (BALB/cAJcl-FOXN1nu/nu) 
from CLEA (Tokyo, Japan) and applied irradiation to the skin using an MX-160Labo X-ray radiation machine 
(Medixtec, Chiba, Japan). We anesthetized the mice by isoflurane inhalation on the radiation table, placed them 
in a lateral position, pulled the dorsal skin up to create a skin fold, and taped the skin to the radiation surface. We 
covered the body and tail with a lead shield, leaving the dorsal skin fold unprotected, and applied 10 Gy ionizing 
radiation. We then housed the mice separately for 4 weeks. We created an 8 mm full-thickness cutaneous ulcer on 
the back of each mouse as described above. There were four groups: irradiated mice with cutaneous ulcer treated 
by human ASC spheroids (product from 0.6 × 106 hASCs, cultured in 3% HA gel for 12 hours; HA ASC sphe-
roids), by the same number of monolayer cultured human ASCs (suspended in 3% HA gel in DMEM with 10% 
FBS; 2D cultured ASCs), or by vehicle (3% HA gel in DMEM with 10% FBS); and normal mice with cutaneous 
ulcer treated by vehicle (n = 3 mice/group); and normal mice with cutaneous ulcer treated by vehicle (n = 3 mice/
group). We photographed the wounds on days 0, 2, 4, 7, 10, 13, 16, and 18.
Statistical analysis. We expressed the results as the mean ± standard error. We used Kruskal-Wallis test to 
compare the wound sizes in both animal models. We applied one-way ANOVAs to the viability assay, the SSEA-3 
quantification, and the comparison of scar-collagen thickness. Tukey’s HSD served as a post-hoc test. We consid-
ered p-values < 0.05 statistically significant.
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